GoodRx Holdings (GDRX) Earnings Analysis

GoodRx Holdings (GDRX) has no confirmed upcoming earnings date. Last quarter (2026-02-25) it beat with EPS 0.09 USD vs 0.09 USD est (0%). It has beaten estimates in 1/2 recent quarters (50%). Trailing P/E 50.00.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does GDRX next report earnings?

No confirmed upcoming earnings date is currently scheduled for GDRX. This page updates as the calendar is published.

GDRX earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-250.09 USD0.09 USD0%Beat
2025-02-270.09 USD0.1 USD-10%Miss

Beat rate: 1/2 (50%) over reported quarters with consensus data.

GDRX valuation and analyst view

Trailing P/E50.00
Trailing EPS0.06036 USD
Price / book1.60
Dividend yield0.00%
Market cap1.02B
Analyst consensusHold (10 buy / 13 hold / 1 sell)
Avg price target3.5 USD

Related research pages

Frequently asked questions

When is GoodRx Holdings (GDRX)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for GDRX. This page updates as the calendar is published.

Did GDRX beat earnings last quarter?

In its 2026-02-25 report, GDRX posted EPS of 0.09 USD versus a 0.09 USD estimate — a beat of 0%.

What is GDRX's earnings track record?

Over the last 2 reported quarters with consensus data, GDRX beat estimates 1 times (50%).

What is GDRX's current P/E ratio and EPS?

GDRX trades at a trailing P/E of 50.00 on trailing EPS of 0.06036454830837721 USD.

What do analysts rate GDRX?

Analyst consensus is "Hold" across 24 ratings (0 strong buy, 10 buy, 13 hold, 1 sell, 0 strong sell). Average 12-month price target: 3.5 USD.